Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals

Journal of Virology

Volumn 78, Issue 18, 2004, Pages 10206-10210

  Du Pasquier, R A ^a,d   Schmitz, J E ^a   Jean Jacques, J ^a   Zheng, Y ^a   Gordon, J ^b   Khalili, K ^b   Letvin, N L ^a   Koralnik, I J ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHROMIUM 51; EPITOPE; HLA A ANTIGEN; PROTEIN P100; PROTEIN VP1; TETRAMER;

ADULT; ARTICLE; CELL SPECIFICITY; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; DEMYELINATION; DISEASE COURSE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; JC VIRUS; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROTECTION; STAINING;

ADULT; CYTOMEGALOVIRUS; DNA-BINDING PROTEINS; HLA-A ANTIGENS; HUMANS; IMMUNOCOMPETENCE; IMMUNODOMINANT EPITOPES; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; PLANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; VIRUS REPLICATION;

EID: 4444348496     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.18.10206-10210.2004     Document Type: Article

References (25)

1. Antinori, A., A. Cingolani, P. Lorenzini, M. L. Giancola, I. Uccella, S. Bossolasco, S. Grisetti, F. Moretti, B. Vigo, M. Bongiovanni, B. Del Grosso, M. I. Arcidiacono, G. C. Fibbia, M. Mena, M. G. Finazzi, G. Guaraldi, A. Ammassari, A. d'Arminio Monforte, P. Cinque, A. De Luca, and the Italian Registry Investigative Neuro AIDS Study Group. 2003. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J. Neurovirol. 9(Suppl. 1):47-53.
2. Boppana, S. B., and W. J. Britt. 1996. Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells. Virology 222:293-296.
3. Catalina, M. D., J. L. Sullivan, K. R. Bak, and K. Luzuriaga. 2001. Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection. J. Immunol. 167:4450-4457.
4. Chen, F. E., G. Aubert, P. Travers, I. A. Dodi, and J. A. Madrigal. 2002. HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy. Cytotherapy 4:41-48.
5. Diamond, D. J., J. York, J. Y. Sun, C. L. Wright, and S. J. Forman. 1997. Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection. Blood 90:1751-1767.
6. Du Pasquier, R. A., K. W. Clark, P. S. Smith, J. T. Joseph, J. M. Mazullo, U. De Girolami, N. L. Letvin, and I. J. Koralnik. 2001. Favorable clinical outcome in HIV-infected individuals with progressive multifocal leukoencephalopathy correlates with JCV-specific cellular immune response. J. Neurovirol. 7:318-322.
7. Du Pasquier, R. A., M. J. Kuroda, J. Schmitz, Y. Zheng, K. Martin, F. Peyrl, M. Lifton, D. Gorgone, P. Autissier, N. L. Letvin, and I. J. Koralnik. 2003. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1p36 in patients with proven or possible progressive multifocal leukoencephalopathy. J. Virol. 77:11918-11926.
8. Du Pasquier, R. A., M. J. Kuroda, Y. Zheng, J. Jean-Jacques, N. L. Letvin, and I. J. Koralnik. 2004. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 127:1970-1978.
9. Gamadia, L. E., R. J. Rentenaar, P. A. Baars, E. B. Remmerswaal, S. Surachno, J. F. Weel, M. Toebes, T. N. Schumacher, I. J. ten Berge, and R. A. van Lier. 2001. Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers. Blood 98:754-761.
10. Gasnault, J., M. Kahraman, M. G. de Goer de Herve, D. Durali, J. F. Delfraissy, and Y. Taoufik. 2003. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy. AIDS 17:1443-1449.
11. + T lymphocytes in healthy seropositive donors. J. Virol. 74:8140-8150.
12. Klemola, E., and L. Kaariainen. 1965. Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. Br. Med. J. 5470:1099-1102.
13. Koralnik, I. J., R. A. Du Pasquier, M. Kuroda, J. E. Schmitz, X. Dang, Y. Zheng, M. Lifton, and N. L. Letvin. 2002. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a cytotoxic T lymphocyte response specific for a dominant JC virus epitope. J. Immunol. 168:499-504.
14. Koralnik, I. J., R. A. Du Pasquier, and N. L. Letvin. 2001. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy. J. Virol. 75:3483-3487.
15. Martinez, A. J., and M. Ahdab-Barmada. 1993. The neuropathology of liver transplantation: comparison of main complications in children and adults. Mod. Pathol. 6:25-32.
16. Miller, N. R., E. O. Major, and W. C. Wallen. 1983. Transfection of human fetal glial cells with molecularly cloned JCV DNA, p. 29-40. In J. L. Sever and D. L. Madden (ed.), Polyomaviruses and human neurological diseases. Alan R. Liss, Inc., New York, N.Y.
17. Padgett, B. L., D. L. Walker, G. M. ZuRhein, R. J. Eckroade, and B. H. Dessel. 1971. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet i:1257-1260.
18. Parker, K. C., M. A. Bednarek, L. K. Hull, U. Utz, B. Cunningham, H. J. Zweerink, W. E. Biddison, and J. E. Coligan. 1992. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. J. Immunol. 149:3580-3587.
19. Polic, B., H. Hengel, A. Krmpotic, J. Trgovcich, I. Pavic, P. Luccaronin, S. Jonjic, and U. H. Koszinowski. 1998. Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection. J. Exp Med. 188:1047-1054.
20. Power, C., J. G. Gladden, W. Halliday, M. R. Del Bigio, A. Nath, W. Ni, E. O. Major, J. Blanchard, and M. Mowat. 2000. AIDS- and non-AIDS-related PML association with distinct p53 polymorphism. Neurology 54:743-746.
21. Salter, R. D., D. N. Howell, and P. Cresswell. 1985. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 21:235-246.
22. Tan, L. C., N. Gudgeon, N. E. Annels, P. Hansasuta, C. A. O'Callaghan, S. Rowland-Jones, A. J. McMichael, A. B. Rickinson, and M. F. Callan. 1999. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers. J. Immunol. 162:1827-1835.
23. Tsomides, T. J., A. Aldovini, R. P. Johnson, B. D. Walker, R. A. Young, and H. N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp Med. 180:1283-1293.
24. Weber, T., C. Trebst, S. Frye, P. Cinque, L. Vago, C. J. Sindic, W. J. Schulz-Schaeffer, H. A. Kretzschmar, W. Enzensberger, G. Hunsmann, and W. Luke. 1997. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J. Infect. Dis. 176:250-254.
25. Wills, M. R., A. J. Carmichael, K. Mynard, X. Jin, M. P. Weekes, B. Plachter, and J. G. Sissons. 1996. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTLs. J. Virol. 70:7569-7579.